Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| POSITIVE MODULATOR | Fibrinogen positive modulator | FDA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hemorrhage | 3 | D006470 | ClinicalTrials |
| Liver Diseases | 3 | D008107 | ClinicalTrials |
| Wounds and Injuries | 3 | D014947 | ClinicalTrials |
| Shock | 3 | D012769 | ClinicalTrials |
| Heart Diseases | 3 | D006331 | ClinicalTrials |
| Hernias, Diaphragmatic, Congenital | 2 | D065630 | ClinicalTrials |
| Hematologic Diseases | 2 | D006402 | ClinicalTrials |
| Postpartum Hemorrhage | 2 | D006473 | ClinicalTrials |
| Digestive System Diseases | 2 | D004066 | ClinicalTrials |
| Aneurysm, Dissecting | 2 | D000784 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2109072 |
CONTENTS